Neoplasms Malignant Active Not Recruiting Phase 1 Trials for Crizotinib (DB08865)

Also known as: Neoplasm Malignant / Malignant Tumors / Malignant Tumor / Cancer / Malignant neoplasm NOS / Cancer NOS / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0047288 (Neoplasms Malignant)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01121588An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)Treatment